309 related articles for article (PubMed ID: 31270972)
1. Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences.
Seo N; Kim H; Cho MS; Lim JS
Korean J Radiol; 2019 Jul; 20(7):1003-1018. PubMed ID: 31270972
[TBL] [Abstract][Full Text] [Related]
2. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
[TBL] [Abstract][Full Text] [Related]
3. MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.
Kim H; Myoung S; Koom WS; Kim NK; Kim MJ; Ahn JB; Hur H; Lim JS
PLoS One; 2016; 11(1):e0146235. PubMed ID: 26730717
[TBL] [Abstract][Full Text] [Related]
4. The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy.
Cote A; Florin FG; Mois E; Elisei R; Badea R; Mare C; Hajjar NA; Iancu C; Lebovici A
Ann Ital Chir; 2018; 89():168-176. PubMed ID: 29848812
[TBL] [Abstract][Full Text] [Related]
5. Advances in organ preserving strategies in rectal cancer patients.
Stijns RCH; Tromp MR; Hugen N; de Wilt JHW
Eur J Surg Oncol; 2018 Feb; 44(2):209-219. PubMed ID: 29275912
[TBL] [Abstract][Full Text] [Related]
6. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
Wang Y; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
[TBL] [Abstract][Full Text] [Related]
7. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
8. Rectal MRI Interpretation After Neoadjuvant Therapy.
Horvat N; El Homsi M; Miranda J; Mazaheri Y; Gollub MJ; Paroder V
J Magn Reson Imaging; 2023 Feb; 57(2):353-369. PubMed ID: 36073323
[TBL] [Abstract][Full Text] [Related]
9. MRI assessment of rectal cancer response to neoadjuvant therapy: a multireader study.
Yuval JB; Patil S; Gangai N; Omer DM; Akselrod DG; Fung A; Harmath CB; Kampalath R; Krehbiel K; Lee S; Liu PS; Millet JD; O'Malley RB; Purysko AS; Veniero JC; Wasnik AP; Garcia-Aguilar J; Gollub MJ
Eur Radiol; 2023 Aug; 33(8):5761-5768. PubMed ID: 36814032
[TBL] [Abstract][Full Text] [Related]
10. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
Yu SK; Tait D; Chau I; Brown G
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
[TBL] [Abstract][Full Text] [Related]
11. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
12. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
13. Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.
Detering R; Borstlap WAA; Broeders L; Hermus L; Marijnen CAM; Beets-Tan RGH; Bemelman WA; van Westreenen HL; Tanis PJ;
Ann Surg Oncol; 2019 Feb; 26(2):437-448. PubMed ID: 30547330
[TBL] [Abstract][Full Text] [Related]
14. Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Kim E; Kim K; Kim SH; Han SW; Kim TY; Jeong SY; Park KJ; Koh J; Kang GH; Chie EK
Cancer Res Treat; 2019 Jul; 51(3):1188-1197. PubMed ID: 30590006
[TBL] [Abstract][Full Text] [Related]
15. Watch & wait - Post neoadjuvant imaging for rectal cancer.
El Homsi M; Bercz A; Chahwan S; Fernandes MC; Javed-Tayyab S; Golia Pernicka JS; Nincevic J; Paroder V; Ruby L; Smith JJ; Petkovska I
Clin Imaging; 2024 Jun; 110():110166. PubMed ID: 38669916
[TBL] [Abstract][Full Text] [Related]
16. Complete response after neoadjuvant therapy in rectal cancer: to operate or not to operate?
Dedemadi G; Wexner SD
Dig Dis; 2012; 30 Suppl 2():109-17. PubMed ID: 23207942
[TBL] [Abstract][Full Text] [Related]
17. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
[TBL] [Abstract][Full Text] [Related]
18. Split scar sign to predict complete response in rectal cancer after neoadjuvant chemoradiotherapy: systematic review and meta-analysis.
Torri GB; Wiethan CP; Langer FW; de Oliveira GS; Meirelles AVB; Horvat N; Tse JR; Dias AB; Altmayer S
Eur Radiol; 2024 Jun; 34(6):3874-3881. PubMed ID: 37979009
[TBL] [Abstract][Full Text] [Related]
19. Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.
Habr-Gama A; Lynn PB; Jorge JM; São Julião GP; Proscurshim I; Gama-Rodrigues J; Fernandez LM; Perez RO
Dis Colon Rectum; 2016 Apr; 59(4):264-9. PubMed ID: 26953984
[TBL] [Abstract][Full Text] [Related]
20. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]